Atlas Trials

Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico

Clinical trial NCT02345343 · COMPLETED

Trial details

NCT number
NCT02345343
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Study type
OBSERVATIONAL
Deep Vein ThrombosisPulmonary Embolism
Start date
2015-05-04
Primary completion
2015-10-07
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.